Evaluation of the Biochemical, Hematological and Genotoxic Parameters of Cebus Apella Treated with N-Methyl-Nitrosurea (NMU) Followed by Treatment with a Complex Homeopathic Compound (Canova)

Rommel Rodríguez Burbano

Abstract


Canova is a homeopathic compound that presents antimutagenic and anticancer properties. N-methyl-nitrosourea is a carcinogenic agent that causes alterations on DNA. This study was conducted to evaluate the antimutagenic effects of Canova on Cebus apella non-human primates treated with N-methyl-nitrosourea. Six animals were randomly assigned in two groups, one composed by two animals, who received only N-methyl-nitrosourea (NMU group) and another one consisting on four animals treated with N-methyl-nitrosourea followed by Canova treatment (CA group). Body weight, biochemical and hematological analysis were performed. Micronuclei test and Comet assay were carried out to evaluate genotoxicity. N-methyl-nitrosourea treatment led to an overall reduction in the hematologic cell count and the administration of Canova limited the adverse effects in the hematologic system on CA group. Canova also reduced micronuclei frequency and the DNA damage index. It suggests that Canova may have a role as an immune response modulator by inducing leukocyte proliferation.

Full Text:

PDF Citation

References


Abud AP, Cesar B, Cavazzani LF, de Oliveira CC, Gabardo J, Buchi Dde F. Activation of bone marrow cells treated with Canova in vitro. Cell Biol Int. 2006; 30:808-16.

Barbosa NBV, Nogueira CW, Guecheva TN, Bellinaso L, Rocha JB. Diphenyl diselenide supplementation delays the development of N-nitroso-N-methylurea-induced mammary tumors. Arch Toxicol. 2008;82:655-63.

Bergman PJ. Cancer immunotherapy. Topics Comp Anim Med. 2009;24:130-36.

Borges da Costa JFF, Leal MF, Silva TCR, Junior EFA, Rezende AP, Muniz JA, Junior ACL, Assumpção PP, Calcagno DQ, Demacki S, Rabenhorst SH, Smith MA, Burbano RR. Experimental Gastric Carcinogenesis in Cebus apella Nonhuman Primates. PLoS ONE. 2011;6(7):e21988.

Burbano RR, Leal MF, Costa JB, Bahia MO, Lima PD, Khayat AS, Seligman IC, Assumpção PP, Buchi DF, Smith MA. Lymphocyte proliferation stimulated by activated human macrophages treated with Canova. Homeopathy. 2009;98:45-48.

Cesar B, Abud AP, Oliveira CC, Cardoso F, Gremski W, Gabardo J, Buchi DF. Activation of mononuclear bone marrow cells treated in vitro with a complex homeopathic medication. Micron. 2008;39:461-70.

Feitsma H, Akay A, Cuppen E. Alkylation damage causes MMR-dependent chromosomal instability in vertebrate embryos. Nucleic Acids Res. 2008;36(12): 4047-56.

Fenech M. The in vitro micronucleus technique. Mutat Res. 2000;455: 81–95.

Klimp AH, de Vries EG, Scherphof GL, Daemen T. A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol. 2002;44:143-61.

Lopes L, Godoy L.M, Oliveira CC, Gabardo J, Schadeck RJ, Buchi DF. Phagocytosis, endosomal/lysosomal system and other cellularaspects of macrophage activation by Canova medication. Micron. 2006;37:277-87.

Oliveira CC, Oliveira SM, Godoy LM, Gabardo J, Buchi DF. Canova, a Brazilian medical formulation, alters oxidative metabolism of mice macrophages. J Infect. 2006;52:420-32.

Oliveira CC, Oliveira SM, Goes VM, Probst CM, Krieger MA, Buchi DF. Gene expression profiling of macrophages following mice treatment with an immunomodulator medication. J Cell Biochem. 2008;104:1364-77.

Parish CR. Cancer immunotherapy: the past, the present and the future. Immunol Cell Biol. 2003;81:106-13.

Pereira WK, Lonardoni MV, Grespan R, Caparroz-Assef SM, Cuman RK, Bersani-Amado CA. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection. J Infect. 2005;51:157-64.

Piemonte MR, Buchi DF. Analysis of IL-2, IFN-gamma and TNF-alpha production, alpha5 beta1 integrins and actin filaments distribution in peritoneal mouse macrophages treated with homeopathic medicament. J Submic Cytol Pathol. 2002;34:255-63.

Riviello MC, Wirz A. Haematology and blood chemistry of Cebus apella in relation to sex and age. J Med Primatol. 2001;30:308-12.

Sato DYO, Wal R, Oliveira CC, Cattaneo RI, Malvezzi M, Gabardo J, Buchi DF. Histopathological and immunophenotyping studies on normal and sarcoma 180-bearing mice treated with a complex homeopathic medication. Homeopathy. 2005;94:26-32.

Seligmann IC, Lima PD, Cardoso PC, Khayat AS, Bahia MO, Buchi DF, Cabral IR, Burbano RR. The anticancer homeopathic composite "Canova Method" is not genotoxic for human lymphocytes in vitro. Genet Mol Res. 2003;2:223-28.

Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184-91.

Sutlu T, Alici E. Natural killer cell-based immunotherapy in cancer: current insights and future prospects. J Internal Med. 2009:266;154-81.




DOI: http://dx.doi.org/10.15383/jbt.2

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

eISSN: 2616-2172

_____________________________________________

Asia Press is a professional Science, Technology and Medicine publisher, who owns rapid publication, Peer-Reviewed, Open Access Journals. Asia Press aims to promote “knowledge sharing”. As you know, the main barrier for free “knowledge sharing” is the cost of publishing and transfer. In order to encourage scholars and scientists to the max, and devote whole power to realize the aim of “knowledge sharing” and the benefit of “all” mankind, Asia Press performs a permanent policy of no charge for publication and access, and always open its door for authors worldwide.